Buy HUMALOG 100IU (INSULIN) Online

Description

Description: HUMALOG 100IU, manufactured by Lilly, is a rapid-acting insulin formulation designed to help manage blood sugar levels in individuals with diabetes mellitus. This injectable medication contains insulin, a hormone essential for regulating glucose metabolism in the body. HUMALOG 100IU offers rapid onset and short duration of action, making it an indispensable tool for controlling postprandial hyperglycemia and managing diabetes effectively.

Active Substance: Insulin is a peptide hormone produced by the pancreas that plays a crucial role in glucose homeostasis. It facilitates the uptake of glucose into cells, where it is utilized for energy production or stored for future use. In individuals with diabetes, either insufficient insulin is produced (Type 1 diabetes) or the body becomes resistant to the effects of insulin (Type 2 diabetes), leading to elevated blood sugar levels. Exogenous insulin therapy, such as HUMALOG 100IU, helps restore normal glucose metabolism and prevent complications associated with uncontrolled diabetes.

Indications: HUMALOG 100IU is indicated for the treatment of:

• Type 1 Diabetes Mellitus: HUMALOG is used as part of a comprehensive treatment regimen that includes basal insulin to provide mealtime coverage and control postprandial glucose excursions.
• Type 2 Diabetes Mellitus: HUMALOG may be prescribed in combination with long-acting insulin or oral antidiabetic agents to improve glycemic control and manage hyperglycemia.

Mechanism of Action: HUMALOG 100IU exerts its effects by:

• Facilitating Glucose Uptake: Insulin binds to insulin receptors on target cells, promoting the translocation of glucose transporters (GLUT4) to the cell membrane, thereby facilitating the uptake of glucose into cells.
• Suppressing Hepatic Glucose Production: Insulin inhibits hepatic gluconeogenesis, the process by which the liver produces glucose from non-carbohydrate precursors, thereby reducing hepatic glucose output and lowering blood sugar levels.
• Promoting Glycogen Synthesis: Insulin stimulates glycogen synthesis in liver and muscle cells, leading to the storage of excess glucose in the form of glycogen, which can be mobilized when needed.

Benefits:

• Rapid Onset: HUMALOG 100IU offers rapid onset of action, with effects observed within 15 minutes of injection, making it ideal for controlling postprandial hyperglycemia and preventing glucose spikes after meals.
• Flexible Dosing: HUMALOG can be administered shortly before or immediately after meals, allowing for flexible dosing and adjustment based on individual carbohydrate intake and glycemic response.
• Improved Glycemic Control: HUMALOG helps maintain target blood sugar levels throughout the day, reducing the risk of acute and chronic complications associated with uncontrolled diabetes.

How to Use: HUMALOG 100IU is administered via subcutaneous injection using a syringe or insulin pen device. The dosage and timing of administration should be individualized based on factors such as meal size, carbohydrate content, blood sugar levels, and insulin sensitivity. It is essential to follow the prescribing healthcare provider’s instructions regarding dosage, administration technique, and monitoring.

Storage: HUMALOG 100IU cartridges should be stored in a refrigerator at a temperature of 2°C to 8°C (36°F to 46°F). Cartridges that are currently in use or intended for immediate use may be kept at room temperature (below 30°C or 86°F) for up to 28 days to avoid discomfort from cold injections. Cartridges should be protected from light and kept away from heat and direct sunlight.

Side Effects: Common side effects of HUMALOG 100IU may include:

• Hypoglycemia (low blood sugar): Symptoms may include shakiness, sweating, palpitations, anxiety, and confusion.
• Injection Site Reactions: These may include redness, swelling, itching, or pain at the injection site.
• Weight Gain: Insulin therapy may lead to modest weight gain due to improved glycemic control and increased nutrient uptake by cells.

Precautions:

• HUMALOG 100IU should not be used in cases of hypoglycemia or hypersensitivity to insulin or any of its excipients.
• Close monitoring of blood sugar levels is essential during insulin therapy to prevent hypoglycemia and adjust insulin doses accordingly.
• Patients should be educated about proper injection technique, rotation of injection sites, and recognition of hypoglycemic symptoms to ensure safe and effective use of HUMALOG.

In summary, HUMALOG 100IU by Lilly is a rapid-acting insulin formulation indicated for the management of diabetes mellitus. With its rapid onset, flexible dosing, and ability to improve glycemic control, HUMALOG provides individuals with diabetes the means to achieve target blood sugar levels and maintain overall health and well-being.